Description

2(1H)-Quinoxalinone,4-[[4-(2-Benzothiazolyl)-1-Piperidinyl]Acetyl]-3,4-Dihydro-(9Ci) is a sophisticated heterocyclic organic compound that serves as a key advanced intermediate in pharmaceutical research and development. Its complex molecular architecture, featuring fused quinoxalinone and benzothiazolyl-piperidine moieties, makes it a valuable scaffold for designing novel bioactive molecules. This high-purity compound is primarily utilized by R&D chemists and process development scientists in the pharmaceutical and agrochemical industries for the synthesis of potential drug candidates and specialty chemicals.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of novel drug candidates, particularly for central nervous system (CNS) and anti-infective targets.
• Agrochemical Research: Used in the development of new pesticides and herbicides, leveraging its heterocyclic structure for bioactivity.
• Chemical Biology Probe: Acts as a scaffold or precursor for creating molecular probes to study enzyme function and biological pathways.
• Material Science Research: Investigated as a precursor for organic electronic materials due to its conjugated system and potential for charge transport.
• Academic & Institutional R&D: Employed in university and research institute laboratories for synthetic methodology development and novel compound library generation.
• Contract Research & Manufacturing (CRO/CMO): Supplied to service organizations supporting pharmaceutical and chemical companies with custom synthesis and scale-up.

Basic Information

Product Name	2(1H)-Quinoxalinone,4-[[4-(2-Benzothiazolyl)-1-Piperidinyl]Acetyl]-3,4-Dihydro-(9Ci)
CAS No.	606083-40-3
Molecular Formula	C22H20N4O2S
Molecular Weight	404.49 g/mol
Synonyms	4-[[4-(2-Benzothiazolyl)-1-piperidinyl]acetyl]-3,4-dihydro-2(1H)-quinoxalinone; 4-[2-[4-(1,3-Benzothiazol-2-yl)piperidin-1-yl]acetyl]-3,4-dihydro-1H-quinoxalin-2-one; 606083-40-3; UNII-7K1JZW805N; 7K1JZW805N; 4-({[4-(1,3-Benzothiazol-2-yl)piperidin-1-yl]acetyl})quinoxalin-2(1H)-one; 3,4-Dihydro-4-({2-[4-(2-benzothiazolyl)-1-piperidinyl]-2-oxoethyl})quinoxalin-2(1H)-one
EINECS	Contact for details

Quality Control

Our 2(1H)-Quinoxalinone,4-[[4-(2-Benzothiazolyl)-1-Piperidinyl]Acetyl]-3,4-Dihydro-(9Ci) is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity for research applications. Each lot undergoes comprehensive analytical characterization using HPLC, NMR, and mass spectrometry to confirm identity and purity. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting critical quality attributes. We support cGMP compliance for advanced intermediates intended for pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at a controlled room temperature (typically 15-25°C). The compound may be light-sensitive; prolonged exposure to light should be avoided. Keep container tightly sealed when not in use to protect from moisture.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.